Detalhe da pesquisa
1.
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 390(2): 118-131, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38197815
2.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
N Engl J Med
; 389(2): 137-147, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272535
3.
A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non-small cell lung cancer with EGFR mutation.
Cancer
; 129(3): 405-414, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36451343
4.
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
N Engl J Med
; 382(1): 41-50, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31751012
5.
Effects of Uncertainty, Appraisal of Uncertainty, and Self-Efficacy on the Quality of Life of Elderly Patients with Lung Cancer Receiving Chemotherapy: Based on Mishel's Theory of Uncertainty.
Medicina (Kaunas)
; 59(6)2023 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37374255
6.
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study.
Lancet Oncol
; 23(6): 781-792, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576957
7.
The new diagnostic criteria for myelodysplasia-related acute myeloid leukemia is useful for predicting clinical outcome: comparison of the 4th and 5th World Health Organization classifications.
Ann Hematol
; 101(12): 2645-2654, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220882
8.
A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer.
Br J Cancer
; 124(4): 713-720, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33191408
9.
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
N Engl J Med
; 379(21): 2040-2051, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280635
10.
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(2): 113-125, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29151359
11.
Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 379(21): 2027-2039, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280657
12.
The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents.
Acta Haematol
; 144(6): 649-659, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233332
13.
The patient's perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050.
Future Oncol
; 17(7): 783-794, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33164569
14.
Analysis of EGFR mutation status in malignant pleural effusion and plasma from patients with advanced lung adenocarcinoma.
Clin Chem Lab Med
; 58(9): 1547-1555, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32229655
15.
Altered integrity of corpus callosum in generalized epilepsy in relation to seizure lateralization after corpus callosotomy.
Neurosurg Focus
; 48(4): E15, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32234995
16.
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Lancet Oncol
; 20(12): 1670-1680, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601496
17.
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study.
Lancet Oncol
; 20(12): 1681-1690, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587882
18.
Molecular alterations and poziotinib efficacy, a pan-HER inhibitor, in human epidermal growth factor receptor 2 (HER2)-positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2-positive breast cancer patients.
Int J Cancer
; 145(6): 1669-1678, 2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30720867
19.
A Case of Acquired Amegakaryocytic Thrombocytopenia with Anti-c-mpl Autoantibody: Comparison with Idiopathic Thrombocytopenic Purpura.
Acta Haematol
; 142(4): 239-243, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132762
20.
Effects of dose modifications on the safety and efficacy of dacomitinib for EGFR mutation-positive non-small-cell lung cancer.
Future Oncol
; 15(24): 2795-2805, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31313942